EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS.

Trial Profile

EFFICACY AND SAFETY OF 8% CLOBETASOL NAIL LACQUER FORMULATION VERSUS VEHICLE IN NAIL PSORIASIS.

Recruiting
Phase of Trial: Phase II

Latest Information Update: 03 Jul 2012

At a glance

  • Drugs Clobetasol (Primary)
  • Indications Psoriasis
  • Focus Adverse reactions; Therapeutic Use
  • Sponsors Pierre Fabre
  • Most Recent Events

    • 13 Jun 2011 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top